Greenwich Biosciences

Greenwich Biosciences is a biopharmaceutical company that develops cannabinoid prescription medicines. It offers EPIDIOLEX (cannabidiol), a prescription formulation of highly purified, plant-derived cannabidiol (CBD).

Employee Rating

4.3
TypeSubsidiary
Parent CompanyGW Pharmaceuticals
HQCarlsbad, CA, US
Founded2013
Websitegreenwichbiosciences.com
Cybersecurity ratingAMore
Greenwich Biosciences was founded in 2013 and is headquartered in Carlsbad, CA, US
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Greenwich Biosciences

Justin Gover

Justin Gover

Chief Executive Officer
Darren Cline

Darren Cline

Chief Commercial Officer
Scott Giacobello

Scott Giacobello

Chief Financial Officer
Volker Knappertz

Volker Knappertz

Chief Medical Officer
Douglas Snyder

Douglas Snyder

Chief Legal Officer
Show more

Greenwich Biosciences Office Locations

Greenwich Biosciences has an office in Carlsbad
Carlsbad, CA, US (HQ)
5750 Fleet St #200
Show all (1)

Greenwich Biosciences Financials and Metrics

Summary Metrics

Founding Date

2013
Greenwich Biosciences is a subsidiary of GW Pharmaceuticals

Greenwich Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

100/100

SecurityScorecard logo

Greenwich Biosciences Online and Social Media Presence

Embed Graph

Greenwich Biosciences News and Updates

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting

EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies

Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting

- Meeting Highlights Include New Long-Term Data in Tuberous Sclerosis Complex -

Greenwich Biosciences to Present Analysis of Three Clinical Studies of Nabiximols for People with Multiple Sclerosis Related Spasticity at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly

- Results from analysis of three Phase 3 clinical studies showed statistically significant improvement in spasticity in people with multiple sclerosis

Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community

-- Technology provides a new way for the community to communicate and connect -- -- Launching in collaboration with patient advocacy organizations, this web-based, image-recognition technology bridges music and art to provide a voice for those who struggle to express themselves --

Greenwich Biosciences Frequently Asked Questions

  • When was Greenwich Biosciences founded?

    Greenwich Biosciences was founded in 2013.

  • Who are Greenwich Biosciences key executives?

    Greenwich Biosciences's key executives are Justin Gover, Darren Cline and Scott Giacobello.

  • How many employees does Greenwich Biosciences have?

    Greenwich Biosciences has 690 employees.

  • Who are Greenwich Biosciences competitors?

    Competitors of Greenwich Biosciences include Cresco Labs, Trulieve and Purdue Pharma.

  • Where is Greenwich Biosciences headquarters?

    Greenwich Biosciences headquarters is located at 5750 Fleet St #200, Carlsbad.

  • Where are Greenwich Biosciences offices?

    Greenwich Biosciences has an office in Carlsbad.

  • How many offices does Greenwich Biosciences have?

    Greenwich Biosciences has 1 office.